 |
|
|
|||||
Asian stocks opened cautiously as traders assessed strained China-Japan relations and upcoming central bank decisions. Investor caution grew regarding the AI rally's sustainability, with markets anticipating policy announcements from major central banks amid renewed inflation pressures. The Federal Reserve's rate path for 2026 remains uncertain, balancing price pressures and economic activity.
Category:
News and Media
China's central bank continued its gold accumulation for the 13th consecutive month, adding 30,000 troy ounces in November. This sustained buying, which began in November 2024, coincides with gold's strong performance and expectations of Federal Reserve rate cuts. Global central bank purchases have also surged, driven by a need to hedge against the dollar.
Category:
News and Media
Corona Remedies is set to raise 655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growth than the Indian pharmaceutical market. Its sales grew by 13.6% compared to the market's 7.9%. Revenue and net profit have shown strong annual growth. Investors with a high-risk appetite can consider this IPO for the long term.
Category:
News and Media
Nifty is expected to continue its uptrend, consolidating near record highs. Analysts suggest buying on dips, with a breakout potentially pushing the index towards 26,500-26,800. IndusInd Bank and PB Fintech are highlighted as top stock picks, with specific buy recommendations and targets.
Category:
News and Media
Investors can now focus on accrual strategies for fixed-income portfolios. The Reserve Bank of India's interest rate outlook suggests lower returns from capital gains. Fund managers recommend short-term and liquid funds for near-term horizons. Longer horizons can consider short-duration and corporate bond strategies. This approach aims to earn returns from interest receipts.
Category:
News and Media